What Recession? Merck Serono Continues Middle East Expansion Through Innovation And Partnership
This article was originally published in PharmAsia News
Executive Summary
Since global biotech giant Merck Serono opened its Middle East regional office in Dubai three years ago, the company has since expanded to four more countries in the region
You may also be interested in...
Dubiotech Bets On ''If You Build It, They Will Come,'' Despite Funding Shortages
Dubai-based biotech research park Dubiotech unveiled plans for what it is calling a "state-of-art nucleotide laboratory complex," hoping it will draw multinational tenants to the Middle East in force
Dubiotech Bets On ''If You Build It, They Will Come,'' Despite Funding Shortages
Dubai-based biotech research park Dubiotech unveiled plans for what it is calling a "state-of-art nucleotide laboratory complex," hoping it will draw multinational tenants to the Middle East in force
Merck Serono Targets Japan's Underdeveloped Fertility Market, Builds Line Extensions On Vital Products
TOKYO - The pharmaceutical market in Japan is the world's second-largest, but most large companies are pretty well saturated here. Many companies now tout growth projections in China, drawing the regional spotlight away from Japan. But Merck Serono is aggressively promoting its products in Japan, trying to make up for lost time